IRIS
CASTAGNA, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.486
EU - Europa 8.387
AS - Asia 4.200
SA - Sud America 852
AF - Africa 291
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.334
RU - Federazione Russa 1.969
IT - Italia 1.695
SG - Singapore 1.438
GB - Regno Unito 1.418
CN - Cina 1.146
IE - Irlanda 1.133
BR - Brasile 690
SE - Svezia 504
VN - Vietnam 490
FR - Francia 411
HK - Hong Kong 345
DE - Germania 340
UA - Ucraina 261
FI - Finlandia 230
KR - Corea 187
IN - India 171
ZA - Sudafrica 166
BD - Bangladesh 106
NL - Olanda 105
ES - Italia 87
CA - Canada 85
AR - Argentina 60
TR - Turchia 58
PL - Polonia 57
JP - Giappone 43
CI - Costa d'Avorio 33
IQ - Iraq 33
MX - Messico 31
EC - Ecuador 28
MA - Marocco 28
AT - Austria 27
BE - Belgio 27
AU - Australia 24
IR - Iran 23
CZ - Repubblica Ceca 21
CL - Cile 19
ID - Indonesia 17
UZ - Uzbekistan 17
VE - Venezuela 15
KE - Kenya 14
EG - Egitto 13
NG - Nigeria 13
PK - Pakistan 13
CO - Colombia 12
JO - Giordania 12
LT - Lituania 12
NP - Nepal 11
PY - Paraguay 11
RO - Romania 11
SA - Arabia Saudita 11
CH - Svizzera 10
JM - Giamaica 10
PT - Portogallo 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
DZ - Algeria 8
GR - Grecia 8
IL - Israele 7
PH - Filippine 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
ET - Etiopia 6
KG - Kirghizistan 6
MY - Malesia 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
LU - Lussemburgo 5
PA - Panama 5
BB - Barbados 4
CR - Costa Rica 4
EU - Europa 4
KZ - Kazakistan 4
LB - Libano 4
MK - Macedonia 4
OM - Oman 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
AM - Armenia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NI - Nicaragua 3
PE - Perù 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
GY - Guiana 2
HN - Honduras 2
IM - Isola di Man 2
IS - Islanda 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
TM - Turkmenistan 2
Totale 22.224
Salva come PNG Salva come JPEG
Città #
Southend 1.239
Dublin 1.109
Dallas 1.010
Fairfield 749
Singapore 706
Ashburn 621
Moscow 558
Santa Clara 499
San Jose 490
Chandler 420
Woodbridge 332
Hong Kong 329
Wilmington 290
Houston 278
Hefei 272
Seattle 267
Cambridge 255
Beijing 246
Siena 232
Florence 225
Ann Arbor 217
The Dalles 184
Seoul 180
Jacksonville 177
Los Angeles 175
Ho Chi Minh City 163
Johannesburg 152
Lauterbourg 143
Princeton 143
New York 142
Milan 130
Munich 130
Helsinki 128
Council Bluffs 113
Hanoi 109
Rome 76
São Paulo 71
San Mateo 67
Buffalo 62
Shanghai 62
Orem 55
Nanjing 50
Chicago 44
Turku 44
Bengaluru 42
Redondo Beach 42
Boardman 40
San Diego 40
Chennai 39
Lappeenranta 38
London 38
Málaga 37
Tokyo 35
Warsaw 35
Abidjan 33
Montreal 33
Naples 32
Dearborn 30
Brooklyn 29
Saint Petersburg 29
Stockholm 28
Düsseldorf 27
Portsmouth 26
Bologna 25
Brussels 24
Frankfurt am Main 24
Amsterdam 22
Atlanta 22
Da Nang 22
Haiphong 21
Columbus 20
San Francisco 20
Toronto 20
Phoenix 18
Rio de Janeiro 18
Bari 17
Denver 17
Guangzhou 17
Manchester 17
Redwood City 17
Ankara 16
Nuremberg 16
Prato 16
Washington 16
Belo Horizonte 15
Tashkent 15
Vienna 15
Boston 14
Hangzhou 14
Mumbai 14
Tianjin 14
Turin 14
Baghdad 13
Fremont 13
Izmir 13
Zhengzhou 13
Abuja 12
Biên Hòa 12
Brasília 12
Curitiba 12
Totale 14.217
Salva come PNG Salva come JPEG
Nome #
CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI 460
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 371
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 323
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 319
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 319
Rare POMC Mutation in a Patient With Myotonic Dystrophy Type 1 and Adrenocorticotropin Hyperresponse to Corticotropin-Releasing Hormone 315
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 299
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 296
Reference range of serum calcitonin in pediatric population 295
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 292
Approach to and treatment of differentiated thyroid carcinoma 286
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 285
FASTING ENHANCES TKI EFFICACY ON THYROID CANCER CELLS 278
Acute exogenous TSH administration stimulates leptin secretion in vivo 274
Large-scale screening of organ specific autoantibodies in patients with autoimmune thyroid diseases 266
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 265
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 262
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 260
Clinical significance of type 2 iodothyronine deiodinase polymorphism 257
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 254
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 245
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 241
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 238
Role of age at diagnosis in defining potential familial nonmedullary thyroid cancer in kindreds with two affected members 238
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 223
Alteration of Serum Proteome in Levo-Thyroxine-Euthyroid Thyroidectomized Patients 221
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 219
Autoimmune thyroid diseases are more common in patients with prolactinomas: a retrospective case–control study in an Italian cohort 219
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 216
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC 215
Medullary thyroid carcinoma 214
Paradoxical effect of dopamine-agonists on IGF-1 in patients with prolactinoma: the role of weight 214
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 213
SEX HORMONES IN LONG QT SYNDROME AND TORSADES DE POINTES (TDP) 207
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 205
BROX haploinsufficiency in familial nonmedullary thyroid cancer 203
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 203
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 201
Long-Term Clinical Outcome in Familial and Sporadic Papillary Thyroid Carcinoma 199
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 197
Assessing the Prevalence of Male Obesity-Associated Gonadal Dysfunction in Severe Obesity: A Focus on the Impact of Bariatric Surgery and Surgical Approaches 196
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 196
Monitoraggio del nodulo tiroideo benigno in accordo con la classe di rischio ecografica 195
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? 194
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 193
Controlling Nutritional Status (CONUT) Score and Micronutrient Deficiency in Bariatric Patients: Midterm Outcomes of Roux-en-Y Gastric Bypass Versus One Anastomosis Gastric Bypass/Mini Gastric Bypass 193
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 191
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 189
Pilot study on the impact of polymorphisms linked to multi-kinase inhibitor metabolism on lenvatinib side effects in patients with advanced thyroid cancer 187
Preliminary results from whole-genome expression analysis in patients with secondary adrenal insufficiency treated with modified-release hydrocortisone 186
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 184
Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy 184
Normalization of Spexin Levels in Patients with Obesity Submitted to Bariatric Surgery 181
Risk of second malignant neoplasm in familial non-medullary thyroid cancer patients 180
From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer 179
New specific skeletal muscle mass index cut-offs for the assessment of sarcopenia in patients with severe obesity 178
Il carcinoma familiare non midollare della tiroide non sindromico 178
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 176
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 173
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 173
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred 172
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 169
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 168
Tireotossicosi in gravidanza e nel post-partum 165
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 165
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in low and Intermediate DTC Patients 164
Silent thyroiditis following vaccination against COVID-19: report of two cases 163
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series 163
Radioiodine therapy in the different stages of differentiated thyroid cancer 161
New insight in the follow-up strategies of differentiated thyroid cancer 161
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. 158
Familial non-medullary thyroid cancer: a critical review 158
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer 157
Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency: A possible novel iodine deficiency disorder in developed countries 156
Screening of organ-specific autoantibodies in a large cohort of patients with autoimmune thyroid diseases. 156
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 153
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer 153
Nodular Thyroid Disease in the Era of Precision Medicine 152
Improvement of overall survival using TKIs as salvage therapy in advanced thyroid carcinoma: Real‐life data on a single center experience 151
Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors 150
Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study 149
Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity 148
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study 147
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer 145
Eif1ax c.338-2a>t splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion 145
Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery 143
Indication for radioiodine remnant ablation in differentiated thyroid cancer patients: does 2018 Italian consensus change anything? 142
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels 139
Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy 139
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 138
Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients 135
Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma 134
Associazione Americana di Endocrinologia Clinica e Associazione Medici Endocrinologi: algoritmo per la diagnostica dei noduli tiroidei 133
null 126
A case of papillary thyroid cancer without aggressive histological features with nodal metastyases in an older patients 122
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value 121
PAPPA expression in indeterminate thyroid nodules as screening test to select patients for molecular testing 121
Real-world performance of ATA risk estimates in predicting 1-year DTC outcomes: A prospective multicenter study of 2000 patients (ITCO Study #3) 121
Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective 121
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy 120
Totale 19.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.036
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021111 0 0 0 0 0 0 0 0 0 0 0 111
2021/20221.358 120 110 110 141 78 85 38 51 80 149 167 229
2022/20231.787 109 218 219 200 132 365 78 123 168 68 54 53
2023/20241.979 67 48 161 123 138 407 666 78 43 39 44 165
2024/20254.124 93 183 476 273 468 302 161 206 458 210 403 891
2025/20268.779 700 1.108 861 1.197 1.622 328 1.135 365 298 476 458 231
Totale 22.654